Table 3 Univariate analysis of factors affecting symptom control rate in 95 cases
From: Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
Characteristic | One-year symptom control rate (%) | p-value |
|---|---|---|
Age | Â | Â |
< 60 years | 22.6 | 0.5121 |
≥ 60 years | 46.8 |  |
Gender | Â | Â |
Male | 45.1 | 0.1210 |
Female | 29.2 | Â |
ECOG* performance status | Â | Â |
0-2 | 36.2 | 0.8387 |
3-4 | 27.0 | Â |
Primary site | Â | Â |
Colon cancer | 38.8 | 0.9967 |
Rectal cancer | 37.8 | Â |
Symptom | Â | Â |
Pain | 32.1 | 0.1029 |
Bleeding | 69.9 | Â |
Obstruction | 37.5 | Â |
Biologically equivalent dose | Â | Â |
< 40 Gy10 | 28.5 | 0.0089 |
≥ 40 Gy10 | 40.5 |  |
Re-irradiation | Â | Â |
Yes | 41.0 | 0.3750 |
No | 36.5 | Â |
Concurrent chemotherapy | Â | Â |
Yes | 61.3 | 0.0644 |
No | 33.2 | Â |
Adjuvant chemotherapy | Â | Â |
Yes | 32.2 | 0.1986 |
No | 46.8 | Â |